日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Hospitalization profile among pediatric populations with type 1 diabetes mellitus in Australia: An ecological study

澳大利亚1型糖尿病患儿住院情况:一项生态学研究

Naser, Abdallah Y; Alwafi, Hassan; Alsharif, Alaa A; Al Rajeh, Ahmed M; Alqahtani, Jaber S; Aldhahir, Abdulelah M; Jarab, Anan S; Alkhatib, Nimer S; Alhartani, Yosra J; El-Qasem, Asaleh

Economic evaluation of brivaracetam in the adjunctive treatment of patients with focal-onset seizure in Jordan

在约旦,对布瓦西坦作为局灶性癫痫患者辅助治疗药物进行经济学评价

Halloush, Shiraz; Alkhatib, Nimer S; Alfayez, Osamah M; Alkhezi, Omar S; Al Froukh, Rawan; Radaideh, Farah; Naser, Abdallah Y

Budget impact analysis of subcutaneous infliximab (CT-P13 SC) for treating inflammatory bowel disease in Saudi Arabia: Analysis from payer perspective

沙特阿拉伯皮下注射英夫利昔单抗(CT-P13 SC)治疗炎症性肠病的预算影响分析:从支付方角度的分析

Alkhatib, Nimer S; Almutairi, Abdulaali R; Almadi, Majid; Halloush, Shiraz; Al-Ruthia, Yazed Sulaiman H; Rashdan, Omar; Al-Shatnawi, Samah; Azzam, Nahla A; Mosli, Mahmoud H; Badawoud, Amal M; Al Yami, Majed S; Alhossan, Abdulaziz; AlHarbi, Ibtisam

Economic analysis of glucagon like peptide-1 receptor agonists from the Saudi Arabia payer perspective

从沙特阿拉伯支付方的角度对胰高血糖素样肽-1受体激动剂进行经济分析

Alkhatib, Nimer S; Almutairi, Abdulaali R; Alkhezi, Omar S; Alfayez, Osama M; Al Yami, Majed S; Almohammed, Omar A

Economic Evaluation of Talimogene Laherparepvec Plus Ipilimumab Combination Therapy vs Ipilimumab Monotherapy in Patients With Advanced Unresectable Melanoma

晚期不可切除黑色素瘤患者接受Talimogene Laherparepvec联合Ipilimumab治疗与Ipilimumab单药治疗的经济学评价

Almutairi, Abdulaali R; Alkhatib, Nimer S; Oh, Mok; Curiel-Lewandrowski, Clara; Babiker, Hani M; Cranmer, Lee D; McBride, Ali; Abraham, Ivo

Establishing the Validity and Reliability Evidence of Preceptor Assessment of Student Tool

建立导师评估学生工具的有效性和可靠性证据

Zhou, Lili; Almutairi, Abdulaali R; Alsaid, Nimer S; Warholak, Terri L; Cooley, Janet

Chromatin modifiers and the promise of epigenetic therapy in acute leukemia

染色质修饰因子及其在急性白血病表观遗传治疗中的应用前景

Greenblatt, S M; Nimer, S D

Pivotal role for the NFIL3/E4BP4 transcription factor in interleukin 3-mediated survival of pro-B lymphocytes

NFIL3/E4BP4转录因子在白细胞介素3介导的前B淋巴细胞存活中起关键作用

Ikushima, S; Inukai, T; Inaba, T; Nimer, S D; Cleveland, J L; Look, A T

The AML1/ETO fusion protein activates transcription of BCL-2

AML1/ETO融合蛋白激活BCL-2的转录

Klampfer, L; Zhang, J; Zelenetz, A O; Uchida, H; Nimer, S D

Molecular cloning and characterization of NF-IL3A, a transcriptional activator of the human interleukin-3 promoter

NF-IL3A(人白细胞介素-3启动子的转录激活因子)的分子克隆和表征

Zhang, W; Zhang, J; Kornuc, M; Kwan, K; Frank, R; Nimer, S D